The procedure is typically offered to individuals with a body mass index (BMI) of 40 kg/m or above, or 35 kg/m and above with obesity-related health conditions such as type 2 diabetes or hypertension, in line with NICE guidance (CG189)
Ng FM, Sun J, Sharma L, et al
BPC57 was moved to a category 2 list in late 2024, which means that the FDA does not recommend compounding it, but some compounding pharmacies have found ways to re-label it as a different peptide, such as PDA or pentadecapeptide arginate, which is essentially the same thing 10m40s
10.1371/journal.pone.0222768 125
The copper delivery function may influence copper-dependent enzymes including lysyl oxidase (collagen crosslinking), superoxide dismutase, and cytochrome c oxidase